Home » Psychology news » Drug for Lou Gehrig’s disease boosts radiation effectiveness in melanoma laboratory models with brain metastasis

Drug for Lou Gehrig’s disease boosts radiation effectiveness in melanoma laboratory models with brain metastasis

January 12, 2015 by

A drug used to treat Lou Gehrig's disease (ALS) helps radiation be more effective when it was administered to laboratory models with melanoma that had metastasized to the brain, researchers have demonstrated.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>